Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
25/06/2026
Spot gold fell nearly 1% to $3,962.11 per ounce.
Latest
2 m ago
Hong Kong stock market anomaly | Haiqing Zhiyuan (01392.HK) rose more than 11% during the trading day, indicating that the global multispectral AI market is entering a rapid expansion period. The company takes the lead in high-value scenarios.
2 m ago
From the establishment of Sci-Tech Innovation Index within 50 days, the increase reached 4.00%. Among the component stocks, SinnoCore Corporation rose by 14.95%, Biwin Storage rose by 11.53%, Baolitianheng rose by 11.10%, and HGInfo rose by 8.46%.
3 m ago
Computing power chip concept fluctuates and strengthens, Core Source shares rise more than 10% to hit a record high.
4 m ago
There is no limit on the number of times for transitioning from gasoline to electric vehicles. Beijing will conduct a lottery for allocating 9600 ordinary small passenger car permits.
5 m ago
Hong Kong stocks shock | British Silicon Intelligence (03696.HK) skyrocketed more than 15% in the morning. The first AI-driven candidate drug, Rentosertib, is about to start phase III clinical trials.
See all latest